IBTROZI™ (Taletrectinib), FDA-Approved Treatment, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for IBTROZI, a next-generation ROS1 inhibitor for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.